Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 268.45
-0.45 (-0.17%)
Aug 1, 2025, 3:29 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 8.84 billion as of August 1, 2025. Its market cap has increased by 40.38% in one year.
Market Cap
8.84B
Enterprise Value
10.48B
Revenue
6.00B
Ranking
n/a
PE Ratio
28.95
Stock Price
268.45
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 8.84B, an increase of 399.90%. That is a compound annual growth rate of 8.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 8.84B | -7.76% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | 1.15B | 158.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Mankind Pharma | 1,059.19B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |